HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Collagen maturation defects in Ehlers-Danlos keratopathy.

Abstract
Ehlers-Danlos syndrome is one of many inherited abnormalities of connective tissue, specifically collagen. A 16-year-old caucasian female with Type VI Ehlers-Danlos syndrome had five unusual corneal findings, four of which have not been reported in association with Ehlers-Danlos syndrome: micro-cornea (previously reported), cornea plana, keratoconus posticus, stromal haze at the level of Bowman's layer and a peripheral ring opacity suggestive of anterior embryotoxon. Type VI Ehlers-Danlos syndrome is associated with deficient activity of lysyl hydroxylase which ultimately is responsible for cross-linking collagen chains, the source of its tensile strength. Genetic regulation of procollagen formation is believed to be mediated by mRNA. Aggregation and maturation in the extracellular matrix is probably influenced and mediated by its evolving biochemical environment, particularly by complex carbohydrate moieties. An understanding of collagen maturation, and the pathophysiologic and biophysical consequences of abnormalities at this level of biochemical organization, permits more specific understanding of ocular dysmorphology and collagen diseases.
AuthorsM A May, G R Beauchamp
JournalJournal of pediatric ophthalmology and strabismus (J Pediatr Ophthalmol Strabismus) 1987 Mar-Apr Vol. 24 Issue 2 Pg. 78-82 ISSN: 0191-3913 [Print] United States
PMID3585656 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Collagen
Topics
  • Adolescent
  • Collagen (metabolism)
  • Cornea (abnormalities)
  • Corneal Diseases (etiology)
  • Corneal Opacity (etiology)
  • Ehlers-Danlos Syndrome (complications, metabolism)
  • Female
  • Humans
  • Keratoconus (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: